---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-016683"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2026-04-15T23:59:59+00:00"
generated_at: "2026-05-15T06:10:16.113760+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aspire Biopharma signs LOI to acquire Driver Controls Systems unit for $30M

## Summary
- Entered non-binding LOI to acquire Driver Controls Systems business unit of Firefish Topco for $30M cash-free, debt-free.
- Purchase price payable in cash at closing; no new equity raise anticipated.
- Break-up fees of $3.5M applicable under certain circumstances; 30-day no-shop period.
- Company plans to engage Lakewood & Company for management services post-closing.
- Acquisition subject to definitive agreement; LOI non-binding except for exclusivity, confidentiality, and break-up fees.

## SEC filing metadata
- accession: 0001493152-26-016683
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2026-04-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315226016683/0001493152-26-016683-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315226016683/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-016683
- JSON: https://secwatch.observer/filing/0001493152-26-016683.json
- Plain text: https://secwatch.observer/filing/0001493152-26-016683.txt

## Key facts
- Material Agreements
  Aspire Biopharma Holdings, Inc. entered into LOI with Firefish Topco, LLC valued at $30.0 million (effective 2026-04-15).
  - Action: entry
  - Counterparty: Firefish Topco, LLC
  - Value: $30.0 million
  - Effective: 2026-04-15
  source text: On April 15, 2026, Aspire Biopharma Holdings, Inc., a Delaware corporation (the “Company” or “Purchaser”) announced that it has entered into a non-binding letter of intent (the “LOI”) for the acquisition (as described below, the “Acquisition”) of 100% of the Driver Controls Systems business unit ( “DCS” ) of Firefish Topco, LLC
  evidence_url: https://www.sec.gov/Archives/edgar/data/1847345/000149315226016683/0001493152-26-016683-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.